Co-delivery of PDTC and doxorubicin by multifunctional micellar nanoparticles to achieve active targeted drug delivery and overcome multidrug resistance.
about
Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinomaLigand-based targeted therapy: a novel strategy for hepatocellular carcinomaCo-delivery of 10-hydroxycamptothecin with doxorubicin conjugated prodrugs for enhanced anticancer efficacy.Co-delivery of paclitaxel and tetrandrine via iRGD peptide conjugated lipid-polymer hybrid nanoparticles overcome multidrug resistance in cancer cells.Single walled carbon nanohorns as photothermal cancer agents.Use of Nanotechnology to Develop Multi-Drug Inhibitors For Cancer TherapyApplication of chitosan-based nanocarriers in tumor-targeted drug delivery.Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrinMultifunctional particles for melanoma-targeted drug delivery.Chemo-photodynamic combined gene therapy and dual-modal cancer imaging achieved by pH-responsive alginate/chitosan multilayer-modified magnetic mesoporous silica nanocomposites.Advanced materials and processing for drug delivery: the past and the future.pH-sensitive poly(histidine)-PEG/DSPE-PEG co-polymer micelles for cytosolic drug deliveryUnderstanding and targeting cancer stem cells: therapeutic implications and challenges.Anthracycline Nano-Delivery Systems to Overcome Multiple Drug Resistance: A Comprehensive Review.Rational design of multifunctional micelles against doxorubicin-sensitive and doxorubicin-resistant MCF-7 human breast cancer cells.Theranostic applications of nanomaterials in cancer: drug delivery, image-guided therapy, and multifunctional platforms.Recent advances in stealth coating of nanoparticle drug delivery systemsPhysicochemical, pharmaceutical and biological approaches toward designing optimized and efficient hydrophobically modified chitosan-based polymeric micelles as a nanocarrier system for targeted delivery of anticancer drugs.Nanodrug delivery in reversing multidrug resistance in cancer cells.pH-responsive drug-delivery systems.Active radar guides missile to its target: receptor-based targeted treatment of hepatocellular carcinoma by nanoparticulate systems.Dual tumor-targeted poly(lactic-co-glycolic acid)-polyethylene glycol-folic acid nanoparticles: a novel biodegradable nanocarrier for secure and efficient antitumor drug delivery.The achievement of ligand-functionalized organic/polymeric nanoparticles for treating multidrug resistant cancer.Nano-based strategies to overcome p-glycoprotein-mediated drug resistance.Synergistic chemotherapeutic effect of sorafenib-loaded pullulan-Dox conjugate nanoparticles against murine breast carcinoma.Overcoming cancer multidrug resistance by codelivery of doxorubicin and verapamil with hydrogel nanoparticles.A biodegradable polymersome containing Bcl-xL siRNA and doxorubicin as a dual delivery vehicle for a synergistic anticancer effect.Polymeric micelles for multidrug delivery and combination therapy.One-pot synthesis of sustained-released doxorubicin silica nanoparticles for aptamer targeted delivery to tumor cells.A Polymeric Bowl for Multi-Agent Delivery.Drug-loaded nano-microcapsules delivery system mediated by ultrasound-targeted microbubble destruction: A promising therapy method.Multifunctional micelle delivery system for overcoming multidrug resistance of doxorubicin.Elucidation of Molecular Mechanisms Behind the Self-Assembly Behavior of Chitosan Amphiphilic Derivatives Through Experiment and Molecular Modeling.Inhibition of 3-D tumor spheroids by timed-released hydrophilic and hydrophobic drugs from multilayered polymeric microparticles.pH-Disintegrable Polyelectrolyte Multilayer-Coated Mesoporous Silica Nanoparticles Exhibiting Triggered Co-Release of Cisplatin and Model Drug MoleculesChitosan-Grafted Copolymers and Chitosan-Ligand Conjugates as Matrices for Pulmonary Drug Delivery
P2860
Q26823523-1F5F0FCF-0FA7-428B-AD09-5BAB2B327FE1Q28068437-B7EA4F38-12F0-40F0-AB86-BE897856EBD6Q30590874-B1A2E550-ACDA-4A61-9FF6-D6F60C08E374Q33634653-2F848303-82C7-4381-B91E-2900F24CBF99Q33799550-E7E692AA-26A3-4A67-96B2-0D01A80C5D4AQ33859472-72A2A8E2-F1CE-48DD-8EFD-93570CB50270Q34447152-4EEB5E56-7C03-4ED0-B606-61854F500133Q35664758-8EAB9653-B02C-4F23-AB1A-C29CC996F6C5Q36074733-B3DBC583-B2F3-40EF-9051-970229292414Q36317745-05493285-6B61-4A8A-A4B1-5CDFA1A863D9Q36589333-E052F77D-CB68-4E71-B32E-7EEBB5BA966FQ36653608-5B09CE81-D84F-456B-9F9F-4AF3372EFF36Q36907405-EC688404-C173-4B01-8081-CB82F474E118Q37031597-FF3E4195-306B-44E8-AC2A-9470B2340913Q37649864-108CB5A7-7B80-4DB8-AEF6-D7187176A87CQ37938830-D3A70E61-6D5C-4A08-958C-FBD3D94ED876Q37974590-71A4AE27-FC34-4C5A-B3A4-B5D4406DDDD5Q38126555-479787BB-63FA-428D-B3EA-18480B3D95DEQ38234908-5AA09DD6-D4F6-4D12-9C78-8A56BC8C4FCDQ38258883-5709FAAF-D0C6-404F-B627-84F77A336CB7Q38271422-4280642F-64C7-4FEE-8734-4A29BFAF0EB8Q38604983-8FFA641E-6814-4A23-A8D3-4F28328322F8Q38809044-CF51DDF8-F9C1-4233-A1CF-F1A65D1D047DQ38856533-000A9F4E-108F-4A81-8E1C-A1BA25F69403Q38982260-4982D1BD-BA87-4808-92BD-C2EF0ABF08F7Q39000835-98F417A2-52A5-4167-85DC-FAC39E5190AAQ39161466-CE7868EC-0B24-40E7-9CD2-F83E608228D2Q39367399-4C964593-9ECB-45E6-9BB5-3BC534D9EAE4Q39533953-49A9BEF0-7D96-4CB7-9985-7B5649A57125Q40880277-3290BE95-2440-4652-BD22-928637D6C53DQ42564504-37973A86-E776-4CC7-9E38-72E2F2D2AA27Q48662628-9191AF67-1F1A-4E90-877E-CD2EBC13A925Q51812830-7BB1E9AA-2637-4358-A2FC-9F0D66237C62Q53521497-E3B71521-8DD8-4AAC-A318-720F0591EB97Q58068783-9FB4C333-EC83-4887-A240-3A73ED98DF15Q58655855-37CC81D2-6D91-4603-B475-51F1CBFF6A4C
P2860
Co-delivery of PDTC and doxorubicin by multifunctional micellar nanoparticles to achieve active targeted drug delivery and overcome multidrug resistance.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Co-delivery of PDTC and doxoru ...... overcome multidrug resistance.
@en
Co-delivery of PDTC and doxoru ...... overcome multidrug resistance.
@nl
type
label
Co-delivery of PDTC and doxoru ...... overcome multidrug resistance.
@en
Co-delivery of PDTC and doxoru ...... overcome multidrug resistance.
@nl
prefLabel
Co-delivery of PDTC and doxoru ...... overcome multidrug resistance.
@en
Co-delivery of PDTC and doxoru ...... overcome multidrug resistance.
@nl
P2093
P921
P1433
P1476
Co-delivery of PDTC and doxoru ...... overcome multidrug resistance.
@en
P2093
Chong Cheng
Chun-Hu Gu
Haitao Zhang
Shengyong Zhang
Yukun Wang
P304
P356
10.1016/J.BIOMATERIALS.2010.03.066
P577
2010-04-28T00:00:00Z